EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

How does news affect biopharma stock prices?: An event study

Joonhyuk Cho iD, Manish Singh, Andrew W Lo iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0296927 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Joonhyuk Cho und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Financial Engineering, MIT, Cambridge, MA, United States of America. Hauptthemen laut MEDLINE: Biological Products, Drug Industry. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We investigate the impact of information on biopharmaceutical stock prices via an event study encompassing 503,107 news releases from 1,012 companies. We distinguish between pharmaceutical and biotechnology companies, and apply three asset pricing models to estimate their abnormal returns. Acquisition-related news yields the highest positive return, while drug-development setbacks trigger significant negative returns. We also find that biotechnology companies have larger means and standard deviations of abnormal returns, while the abnormal returns of pharmaceutical companies are influenced by more general financial news. To better understand the empirical properties of price movement dynamics, we regress abnormal returns on market capitalization and a sub-industry indicator variable to distinguish biotechnology and pharmaceutical companies, and find that biopharma companies with larger capitalization generally experience lower magnitude of abnormal returns in response to events. Using longer event windows, we show that news related to acquisitions and clinical trials are the sources of potential news leakage. We expect this study to provide valuable insights into how diverse news types affect market perceptions and stock valuations, particularly in the volatile and information-sensitive biopharmaceutical sector, thus aiding stakeholders in making informed investment and strategic decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsDrug IndustryBiotechnology

Substanzen

Biological Products

Autor:innen und Institutionen

  • Laboratory for Financial Engineering, MIT, Cambridge, MA, United States of America.
  • Department of Electrical Engineering and Computer Science, MIT, Cambridge, MA, United States of America.
  • Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA, United States of America.
  • Operations Research Center, MIT, Cambridge, MA, United States of America.
  • Sloan School of Management, MIT, Cambridge, MA, United States of America.
  • Santa Fe Institute, Santa Fe, NM, United States of America.

ORCID-Profile: Joonhyuk Cho, Andrew W Lo

Zitieren

APA

Cho, J., Singh, M., & Lo, A. W. (2024). How does news affect biopharma stock prices?: An event study. PLOS ONE. https://doi.org/10.1371/journal.pone.0296927

Vancouver

Cho J, Singh M, Lo AW. How does news affect biopharma stock prices?: An event study. PLOS ONE. 2024. doi:10.1371/journal.pone.0296927

BibTeX
@article{Cho2024,
  author = {Cho, Joonhyuk and Singh, Manish and Lo, Andrew W},
  title = {How does news affect biopharma stock prices?: An event study},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0296927}
}
Kostenlos starten →